Genpact to Release Third Quarter Results in 2026
PR Newswire
39m ago
Ai Focus
Genpact indicates that the third-quarter financial report will be released after the close of U.S. stocks on November 5, 2026, and a conference call to discuss the results will be held at 5:00 p.m. (Eastern Time) on the same day.
Helpful
No.Help

New York, October 8, 2026 / PRNewswire / -- Genpact (NYSE ticker: G), this " Agentic Operations " company, will announce its financial results for the third quarter of 2026 after the close of U.S. trading on Thursday, November 5, 2026.

After the performance report is released, the management team of Genpact will hold a teleconference at 5:00 PM Eastern Time to discuss the company's performance. Participants are advised to register in advance to obtain the dial-in number and a unique PIN code for easy connection. Although it is recommended to log in as early as possible, registration and connection will remain open throughout the teleconference.

Live webcast will be provided through the Genpact Investor Relations website at that time. Shortly after the meeting, a replay and written record will be published on that website.

About Genpact

Genpact (New York Stock Exchange ticker: G) is a “Agentic Operations” company where AI is combined with context-rich process intelligence. The company operates and transforms critical tasks for enterprises around the world. Genpact's Agentic Operations is built on decades of experience in managing core business processes on a large scale, covering areas such as finance, supply chain, banking, and insurance. The company's flywheel, composed of advanced technology, a trusted data foundation, and deep ecosystem partnerships, enables businesses to rapidly move from experimentation to scale. AI agents bring speed and precision, while human experts provide judgment; together, they deliver results that customers can measure.

For more information, please visit genpact.com, as well as LinkedIn, X, YouTube, and Facebook.

Contact Information:

Tip
$0
Like
0
Save
0
Views 7
HKWDB reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
Pacira BioSciences rises by 44.03%
Pacira BioSciences ( PCRX ) rose 44.03% during trading on Thursday. The article stated that its daily, hourly, and 15-minute technical indicators were all in overbought zones, but the overall trend remained bullish. Previously, there were also media reports indicating that the company had reached a European distribution partnership with Molteni Farmaceutici.
The Cryptonomist
·2026-10-09 06:11:29
3
GoDaddy to Release Q3 2026 Financial Reports on October 29
GoDaddy indicates that financial results for the third quarter will be announced after the close of U.S. markets on October 29, 2026, and a live web conference will be held at 5 p.m. Eastern Time. The recording of the conference will subsequently be available on its investor relations website.
PR Newswire
·2026-10-09 06:11:26
5
ERMProtect Launches AI Security Gap Analysis to Test Control Measures in Response to Emerging Threats
ERMProtect announces the launch of AI Security Gap Analysis, a tool that can map over 100 control measures to recognized frameworks, helping enterprises determine whether their AI security controls are appropriately scope-defined, correctly implemented, and in line with the latest threats. The company states that this service will produce a prioritized roadmap for improvements, which can be re-evaluated after repairs are made.
PR Newswire
·2026-10-09 06:02:05
8
Veeva Summit will showcase industry leaders who innovate and drive research and development as well as quality transformation with AI.
Veeva Systems will host a R&D and Quality Summit in Boston from October 20th to 21st, showcasing AI solutions, automation, and cloud innovations for the biopharmaceutical industry. Institutions such as Eli Lilly, Pfizer, Sanofi, and UCB have been invited to share their practices in drug development, clinical trials, quality control, and manufacturing.
PR Newswire
·2026-10-09 06:02:04
8
Shoulder Innovations Launches InSet Go Commercial Release
Shoulder Innovations announces the launch of a limited user release for InSet Go, a next-generation glenoid implant that has already undergone its first surgical procedure. The company states that this product continues with its InSet technical design principles and is expected to simplify the surgical process and reduce surgery time.
PR Newswire
·2026-10-09 06:02:02
7
View More